Low-density lipoprotein. A lipoprotein that delivers fat molecules to cells throughout the body. Commonly known as the “bad” cholesterol because higher levels of LDL have been associated with the progression of atherosclerosis and blockage of the arteries.
« Back to Glossary IndexNews
Related News
We’re thrilled to announce a new partnership between the Fanconi Cancer Foundation (FCF) and the American Cancer Society (ACS): the Fanconi Cancer Foundation Discovery Boost Grant. This grant program will fuel innovative research aimed at preventing, detecting, and treating cancers associated with Fanconi anemia (FA).
My lab’s vision for the next five years is to apply what we have learned to develop molecules that can alter FA protein behavior. These could be used to treat cancer or alter gene editing outcomes.
People with rare diseases like FA often rely on a combination of healthcare programs and insurance coverage. Any change that reduces access to care or increases out-of-pocket costs can have real-world consequences for our community.